Research

Mixed

Marine algae-derived compounds (fucoxanthin, alginates, fucoidans, phlorotannins) act as anti-obesity agents through mechanisms including pancreatic lipase inhibition, suppression of adipocyte differentiation, and enhancement of energy expenditure.

Marine algae extracts like fucoxanthin and alginates show promise for weight management by blocking fat absorption and increasing energy burn in lab studies. However, current human evidence is limited to short-term effects on satiety or specific supplements. Do not expect these to replace diet and exercise, and be aware that they are not yet approved as standalone obesity drugs due to a lack of long-term human data.

ModerateSupportsMEDIUM confidence
Four major bioactive compounds from seaweeds which have the potential as anti-obesity agents are fucoxanthin, alginates, fucoidans and phlorotannins. The anti-obesity effects of such compounds are due to several mechanisms, which include the inhibition of lipid absorption and metabolism (e.g., fucoxanthin and fucoidans), effect on satiety feeling (e.g., alginates), and inhibition of adipocyte differentiation (e.g., fucoxanthin).
Chu Wan-Loy et al. · Marine Drugs · 2016

Why this rating

The paper is a review of pre-clinical (animal/cell) and limited human studies; it explicitly states that long-term human trials are needed.

Source

Marine Algae as a Potential Source for Anti-Obesity Agents

Chu Wan-Loy et al. · Marine Drugs · 2016

DOI 10.3390/md14120222

narrative_reviewCited 179×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →